RECENT ONSET TYPE1 DIABETES

Clinical trials for RECENT ONSET TYPE1 DIABETES explained in plain language.

Never miss a new study

Get alerted when new RECENT ONSET TYPE1 DIABETES trials appear

Sign up with your email to follow new studies for RECENT ONSET TYPE1 DIABETES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Race to save insulin cells in new diabetes patients

Disease control Terminated

This study tested whether an oral medication called ladarixin could help preserve the body's remaining insulin-producing cells in people recently diagnosed with type 1 diabetes. About 140 patients aged 14-45 took either ladarixin or a placebo for one year, with follow-up for anot…

Matched conditions: RECENT ONSET TYPE1 DIABETES

Phase: PHASE2 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

RECENT ONSET TYPE1 DIABETES

Get alerted when new RECENT ONSET TYPE1 DIABETES trials appear

Race to save insulin cells in new diabetes patients